SC 13D

Company

aTYR PHARMA INC

Filed

September 10, 2018

Accession Number

0001564590-18-022883

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →